Oxford Nanopore said it has started preparing for a potential initial public offering, which could value the U.K.-based biotech revolutionizing DNA sequencing at more than £2 billion ($3 billion). Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado Comentários